- Home
- CCU vs CGON Comparison
CCU vs CGON Comparison
Compare CCU & CGON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCU
- CGON
- Stock Information
- Founded
- CCU 1850
- CGON 2010
- Country
- CCU Chile
- CGON United States
- Employees
- CCU N/A
- CGON N/A
- Industry
- CCU Beverages (Production/Distribution)
- CGON
- Sector
- CCU Consumer Staples
- CGON
- Exchange
- CCU Nasdaq
- CGON NYSE
- Market Cap
- CCU 2.0B
- CGON 2.3B
- IPO Year
- CCU 1992
- CGON 2024
- Fundamental
- Price
- CCU $11.66
- CGON $29.08
- Analyst Decision
- CCU Strong Sell
- CGON Strong Buy
- Analyst Count
- CCU 2
- CGON 10
- Target Price
- CCU $9.70
- CGON $65.11
- AVG Volume (30 Days)
- CCU 176.8K
- CGON 809.2K
- Earning Date
- CCU 02-25-2025
- CGON 02-02-2025
- Dividend Yield
- CCU 1.48%
- CGON N/A
- EPS Growth
- CCU 16.02
- CGON N/A
- EPS
- CCU 0.39
- CGON N/A
- Revenue
- CCU $2,795,960,314.00
- CGON $684,000.00
- Revenue This Year
- CCU $7.56
- CGON $210.00
- Revenue Next Year
- CCU $6.29
- CGON N/A
- P/E Ratio
- CCU $14.97
- CGON N/A
- Revenue Growth
- CCU N/A
- CGON 258.12
- 52 Week Low
- CCU $10.00
- CGON $25.77
- 52 Week High
- CCU $13.74
- CGON $50.23
- Technical
- Relative Strength Index (RSI)
- CCU 56.20
- CGON 44.86
- Support Level
- CCU $11.41
- CGON $27.70
- Resistance Level
- CCU $11.82
- CGON $29.69
- Average True Range (ATR)
- CCU 0.24
- CGON 1.43
- MACD
- CCU 0.01
- CGON 0.16
- Stochastic Oscillator
- CCU 78.95
- CGON 31.29
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.